Vertex Pharmaceuticals (VRTX) EPS (Basic) (2009 - 2026)
Vertex Pharmaceuticals' (VRTX) quarterly EPS (Basic) came in at $4.06 in Q1 2026, up 61.34% year-on-year from $2.52 in Q1 2025, and down 12.86% quarter-over-quarter from $4.66 in Q4 2025.
Vertex Pharmaceuticals (VRTX) EPS (Basic) (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $4.06 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 61.34% year-over-year to $4.06 in Q1 2026; TTM through Mar 2026 was $17.07, a 543.53% increase from a year earlier, with the FY2025 full-year figure at $15.46, up 844.44% from the prior year.
- EPS (Basic) eased to $4.06 in Q1 2026 per VRTX's latest filing, from $4.66 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.66 in Q4 2025 and bottomed at -$13.92 in Q2 2024.
- The 5-year median for EPS (Basic) is $3.63 (2022), against an average of $2.61.
- Across the five-year window, EPS (Basic) surged 1124.3% in 2022 and slumped 491.83% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at $3.2 in 2022, then gained by 17.57% to $3.76 in 2023, then dropped by 5.83% to $3.54 in 2024, then jumped by 31.58% to $4.66 in 2025, then retreated by 12.86% to $4.06 in 2026.
- Per Business Quant, the three latest VRTX EPS (Basic) figures stand at $4.06 (Q1 2026), $4.66 (Q4 2025), and $4.24 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.06 |
| Dec 31, 2025 | 4.66 |
| Sep 30, 2025 | 4.24 |
| Jun 30, 2025 | 4.02 |
| Mar 31, 2025 | 2.52 |
| Dec 31, 2024 | 3.54 |
| Sep 30, 2024 | 4.05 |
| Jun 30, 2024 | -13.92 |
| Mar 31, 2024 | 4.26 |
| Dec 31, 2023 | 3.76 |
| Sep 30, 2023 | 4.01 |
| Jun 30, 2023 | 3.55 |
| Mar 31, 2023 | 2.72 |
| Dec 31, 2022 | 3.20 |
| Sep 30, 2022 | 3.63 |
| Jun 30, 2022 | 3.17 |
| Mar 31, 2022 | 2.99 |
| Dec 31, 2021 | 2.99 |
| Sep 30, 2021 | 3.30 |
| Jun 30, 2021 | 0.26 |